Document:

Restructuring Agreement, dated as of July 25, 2007

 Exhibit 10.1 
 RESTRUCTURING AGREEMENT 
 This Restructuring Agreement (this “Agreement”) is
dated as of July 25, 2007, by and among GlobalOptions Group, Inc., a Delaware corporation (the “Company”), and the holders of the Company’s securities whose signatures appear on the signature pages attached hereto (each,
a “Holder” and, collectively, the “Holders”). 
 Recitals: 
 WHEREAS, certain of the Holders as of the close of business on June 11, 2007 (each, a “Series A Holder” and, collectively, the
“Series A Holders”) hold (a) an aggregate of 6,330 shares of Series A Convertible Preferred Stock, par value $.001 per share and stated value $1,000 per share (the “Series A Preferred Shares”), of the Company,
convertible into an aggregate of 395,625 shares of the Company’s common stock, par value $.001 per share (“Common Stock”), at a conversion price of $16.00 per share, and (b) warrants to purchase an aggregate of 125,015
shares of Common Stock originally issued on or about June 24, 2005 and having a current exercise price per share of $16.00 (the “AA Warrants”), in each case issued pursuant to that Subscription Agreement with respect to the
Series A Preferred Shares and AA Warrants by and among the Company and Series A Holders (the “Series A Subscription Agreement”); and 
 WHEREAS, certain of the Holders who do not also hold Series A Preferred Shares as of the close of business on June 11, 2007 (each, a “Standalone Warrantholder” and, collectively, the
“Standalone Warrantholders”) hold AA Warrants to purchase an aggregate of 26,376 shares of Common Stock; and 
 WHEREAS,
certain of the Holders as of the close of business on June 11, 2007 (each, a “Series BB/C Warrantholder” and, collectively, the “Series BB/C Warrantholders”) hold the following warrants of the Company issued in
connection with the transactions contemplated by the Series A Subscription Agreement: (a) warrants to purchase an aggregate of 292,984 shares of Common Stock originally issued on or about June 24, 2005 and having a current exercise price
per share of $16.00 (the “BB Warrants”); and/or (b) warrants to purchase an aggregate of 75,009 shares of Common Stock originally issued on or about June 24, 2005 and having a current exercise price per share of $16.00
(the “C Warrants” and, together with the B Warrants, the “BB/C Warrants”); and 
 WHEREAS, the Series A
Subscription Agreement sets forth certain registration rights with respect to the shares of Common Stock issuable upon conversion or exercise of the Series A Preferred Shares, the AA Warrants and the BB/C Warrants; and 
 WHEREAS, certain of the Holders as of the close of business on June 11, 2007 (each, a “BH Warrantholder” and, collectively, the
“BH Warrantholders”) hold warrants to purchase an aggregate of 31,250 shares of Common Stock originally issued on or about March 10, 2006 and having a current exercise price per share of $20.00 (the “BH
Warrants”); and 
 WHEREAS, certain of the Holders as of the close of business on June 11, 2007 (each, a “Series B
Holder” and, collectively, the “Series B Holders”) hold (a) an aggregate of 53,070 shares of Series B Convertible Preferred Stock, par value $.001 per share and stated value $1,000 per share (the “Series B
Preferred Shares”), of the Company, convertible into an aggregate of 

 
3,316,875 shares of Common Stock at a conversion price of $16.00 per share, and (b)(i) warrants to purchase an aggregate of 1,160,908 shares of Common Stock
originally issued on or about June 29, 2006 and having a current exercise price per share of $17.20 (the “B-1 Warrants”), and (ii) warrants to purchase an aggregate of 1,185,874 shares of Common Stock originally issued on
or about June 29, 2006 and having a current exercise price per share of $22.32 (the “B-2 Warrants” and, together with the B-1 Warrants, the “Series B Warrants” and, together with the Series A Preferred Shares,
the AA Warrants, the BB/C Warrants, the BH Warrants and the Series B Preferred Shares, the “Old Securities”), in each case issued in connection with the transactions contemplated by the Convertible Note Purchase Agreement, dated as
of June 28, 2006, by and among the Company and Series B Holders (the “Note Purchase Agreement”); and 
 WHEREAS,
certain of the Holders are party to an Investor Rights Agreement, dated as of June 28, 2006, as amended (the “Series B Investor Rights Agreement”), with respect to the shares of Common Stock issuable upon conversion or exercise
of the Series B Preferred Shares and the Series B Warrants; and 
 WHEREAS, subject to the terms and conditions set forth herein, the Company
and the Series A Holders desire to cancel and retire the Series A Preferred Shares, cancel and terminate the AA Warrants held by the Series A Holders and terminate any and all of their respective rights and obligations under the Series A
Subscription Agreement and the Certificate of Designations, Powers, Preferences and Other Rights and Qualifications of Series A Convertible Preferred Stock (the “Series A Certificate of Designation”), and the Series A Holders are
willing to receive, in consideration of the cancellation and retirement of the Series A Preferred Shares and the cancellation and termination of the AA Warrants held by them, (a) an aggregate of 6,330 shares of Series C Convertible Preferred
Stock, par value $.001 per share and stated value $1,000 per share (the “Series C Preferred Shares”), of the Company, convertible into an aggregate of 422,000 shares of Common Stock at a conversion price of $15.00 per share, and
(b) an aggregate of 197,813 shares of Common Stock; 
 WHEREAS, subject to the terms and conditions set forth herein, the Company and
the Standalone Warrantholders desire to cancel and terminate the AA Warrants held by the Standalone Warrantholders, and the Standalone Warrantholders are willing to receive, in consideration of the cancellation and termination of the AA Warrants
held by them, an aggregate of 5,276 shares of Common Stock; and 
 WHEREAS, subject to the terms and conditions set forth herein, the Company
and the Series BB/C Warrantholders desire to cancel and terminate the BB/C Warrants held by the Series BB/C Warrantholders, and the Series BB/C Warrantholders are willing to receive, in consideration of the cancellation and termination of the BB/C
Warrants held by them, an aggregate of 73,599 shares of Common Stock; and 
 WHEREAS, subject to the terms and conditions set forth herein,
the Company and the BH Warrantholders desire to cancel and terminate the BH Warrants, and the BH Warrantholders are willing to receive, in consideration of the cancellation and termination of the BH Warrants held by them, an aggregate of 6,250
shares of Common Stock; and 
 WHEREAS, subject to the terms and conditions set forth herein, the Company and the 

  

 2 

 
Series B Holders desire to cancel and retire the Series B Preferred Shares, cancel and terminate the Series B Warrants and terminate any and all of their
respective rights and obligations under the Note Purchase Agreement and the Certificate of Designations of the Powers, Preferences and Relative, Participating, Optional and Other Special Rights of Preferred Stock and Qualifications, Limitations and
Restrictions Thereof of Series B Convertible Preferred Stock (the “Series B Certificate of Designation” and, together with the Series A Subscription Agreement, the Series A Certificate of Designation, the AA Warrants, the BB/C
Warrants, the BH Warrants, the Note Purchase Agreement, the Series B Warrants and the Series B Investor Rights Agreement, the “Prior Transaction Documents”), and the Series B Holders are willing to receive, in consideration of the
cancellation and retirement of the Series B Preferred Shares and the cancellation and termination of the Series B Warrants held by them, (a) an aggregate of 53,070 Series C Preferred Shares, convertible into an aggregate of 3,538,000 shares of
Common Stock at a conversion price of $15.00 per share, and (b) an aggregate of 1,658,438 shares of Common Stock; and 
 WHEREAS, if the
issuance of shares of Common Stock to any Holder pursuant to the terms hereof (any such Holder being hereinafter referred to as a “Blocked Holder”) would result in the beneficial ownership by such Blocked Holder and its affiliates
(as defined in Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”)), and any other persons or entities whose beneficial ownership of Common Stock would be aggregated with the Blocked Holder’s for
purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (including shares held by any “group” (as defined in Section 13(d) of the Exchange Act and applicable regulations
of the Securities and Exchange Commission (the “Commission”)) of which the Blocked Holder is a member, but, for avoidance of doubt, excluding shares of Common Stock issuable upon conversion or exercise of securities or rights to
acquire securities that are subject to similar beneficial ownership caps), of in excess of 4.99% of the total number of shares of Common Stock issued and outstanding immediately following the Closing (the “Beneficial Ownership
Cap”), then such Blocked Holder shall have the option to receive either (i) shares of Common Stock pursuant to the terms hereof up to the Beneficial Ownership Cap and, in lieu of the issuance to such Blocked Holder of shares of Common
Stock in excess of the Beneficial Ownership Cap, shares of Series D Convertible Preferred Stock, par and stated value of $.001 per share (the “Series D Preferred Shares”), of the Company convertible into the number of shares of
Common Stock such Blocked Holder would have otherwise received but for such Beneficial Ownership Cap (the “Common Stock/Series D Option”) or (ii) in lieu of the issuance to such Blocked Holder of any shares of Common Stock
pursuant to the terms hereof, Series D Preferred Shares convertible into the number of shares of Common Stock such Blocked Holder would have otherwise received pursuant to the terms hereof (the “Series D Option”); and 
 WHEREAS, the Company and the Holders desire to amend each of the Series A Subscription Agreement and the Series B Investor Rights Agreement to provide
for their termination effective as of the Closing Date and to enter into a new registration rights agreement, substantially in the form attached as Exhibit A hereto (the “New Registration Rights Agreement”), effective as of
the Closing Date, with respect to the New Securities (as hereinafter defined). 
  

 3 

 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby
agreed and acknowledged, the parties hereby agree as follows: 
 AGREEMENT: 
 1. Restructuring. 
 (a) Upon
the terms and subject to the conditions set forth in this Agreement, at the Closing: 
 (i) each Series A Holder shall deliver to the Company
all of the Series A Preferred Shares and AA Warrants owned beneficially or of record by it for cancellation and retirement, or cancellation and termination, by the Company, and the Company shall, in consideration of the cancellation and retirement
of such Series A Preferred Shares and cancellation and termination of such AA Warrants, issue and deliver to each such Series A Holder the number of Series C Preferred Shares, the number of shares of Common Stock and/or the number of Series D
Preferred Shares (as applicable) set forth next to such Series A Holder’s name on Schedule I hereto; 
 (ii) each Standalone
Warrantholder shall deliver to the Company all of the AA Warrants owned beneficially or of record by it for cancellation and termination by the Company, and the Company shall, in consideration of the cancellation and termination of such AA Warrants,
issue and deliver to each such Standalone Warrantholder the number of shares of Common Stock and/or the number of Series D Preferred Shares (as applicable) set forth next to such Standalone Warrantholder’s name on Schedule II hereto;

 (iii) each Series BB/C Warrantholder shall deliver to the Company all of the BB/C Warrants owned beneficially or of record by it for
cancellation and termination by the Company, and the Company shall, in consideration of the cancellation and termination of such BB/C Warrants, issue and deliver to each such Series BB/C Warrantholder the number of shares of Common Stock and/or the
number of Series D Preferred Shares (as applicable) set forth next to such Series BB/C Warrantholder’s name on Schedule III hereto; 
 (iv) each BH Warrantholder shall deliver to the Company all of the BH Warrants owned beneficially or of record by it for cancellation and termination by the Company, and the Company shall, in consideration of the cancellation and
termination of such BH Warrants, issue and deliver to each such BH Warrantholder the number of shares of Common Stock and/or the number of Series D Preferred Shares (as applicable) set forth next to such BH Warrantholder’s name on Schedule
IV hereto; and 
 (v) each Series B Holder shall deliver to the Company all of the Series B Preferred Shares and Series B Warrants owned
beneficially or of record by it for cancellation and retirement, or cancellation and termination, by the Company, and the Company shall, in consideration of the cancellation and retirement of such Series B Preferred Shares and cancellation and
termination of such Series B Warrants, issue and deliver to each such Series B Holder the number of Series C Preferred Shares, the number of shares of Common Stock and/or the number of Series D Preferred Shares (as applicable) set forth next to such
Series B Holder’s name on Schedule V hereto. 
  

 4 

 The (i) Series C Preferred Shares, (ii) Series D Preferred Shares (including any Series D Preferred Shares
issuable upon conversion of the Series C Preferred Shares), (iii) shares of Common Stock issuable upon conversion of the Series C Preferred Shares, (iv) shares of Common Stock issuable upon conversion of the Series D Preferred Shares, and
(iv) shares of Common Stock to be issued and delivered by the Company pursuant to this Section 1(a) are sometimes collectively referred to herein as the “New Securities”. 
 (b) A Blocked Holder must have notified the Company in writing prior to the effective date of this Agreement of its election to receive the Series D
Option, otherwise a Blocked Holder will be deemed to have elected to receive the Common Stock/Series D Option. A Blocked Holder’s election of the Series D Option will be reflected on the appropriate schedule(s) to this Agreement. 
 (c) The closing under this Agreement (the “Closing”) shall take place at the
offices of Olshan Grundman Frome Rosenzweig & Wolosky LLP, Park Avenue Tower, 65 East 55th Street, New
York, New York 10022 upon the satisfaction of each of the conditions set forth in Sections 4 and 5 hereof (the “Closing Date”). 
 (d) The designations, rights, preferences and other terms and provisions of the Series C Preferred Shares are set forth in the Certificate of Designations of the Powers, Preferences and Relative, Participating, Optional and Other Special
Rights of Preferred Stock and Qualifications, Limitations and Restrictions Thereof of Series C Convertible Preferred Stock, substantially in the form attached as Exhibit B hereto (the “Series C Certificate of Designation”).
The designations, rights, preferences and other terms and provisions of the Series D Preferred Shares are set forth in the Certificate of Designations of the Powers, Preferences and Relative, Participating, Optional and Other Special Rights of
Preferred Stock and Qualifications, Limitations and Restrictions Thereof of Series D Convertible Preferred Stock, substantially in the form attached as Exhibit C hereto (the “Series D Certificate of Designation”). 

2. Representations, Warranties and Covenants of the Holders. Each of the Holders hereby makes the following representations and
warranties to the Company, and covenants for the benefit of the Company, with respect solely to itself and not with respect to any other Holder: 
 (a) If a Holder is an entity, such Holder is a corporation, limited liability company or partnership duly incorporated or organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or
organization. 
 (b) Each Holder is, and immediately prior to the Closing will be, the record and beneficial owner of the number and type of
Old Securities set forth next to its name on the schedules hereto, free and clear of any and all liens, pledges, security interests, options, charges, encumbrances, agreements or claims of any kind whatsoever (collectively,
“Liens”), other than agreements that will be terminated upon the Closing. On the Closing Date, each Holder’s delivery of such Holder’s Old Securities to the Company will convey to the Company lawful, valid and marketable
title to such Old Securities, free and clear of any and all Liens. 
  

 5 

 (c) This Agreement has been duly authorized, validly executed and delivered by each Holder and is a valid
and binding agreement and obligation of each Holder enforceable against such Holder in accordance with its terms, subject to limitations on enforcement by general principles of equity and by bankruptcy or other laws affecting the enforcement of
creditors’ rights generally, and each Holder has full right, power and authority to execute and deliver this Agreement and the other agreements and documents contemplated hereby and to perform its obligations hereunder and thereunder.

 (d) Each Holder understands that the New Securities to be issued and delivered to such Holder hereunder are being offered and sold to it
in reliance on specific provisions of federal and state securities laws and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of each Holder set forth herein
for purposes of qualifying for exemptions from registration under the Securities Act and applicable state securities laws. Each Holder understands that no United States federal or state agency or any government or governmental agency has passed upon
or made any recommendation or endorsement of the New Securities. 
 (e) Each Holder is an “accredited investor” (as defined in Rule
501 of Regulation D under the Securities Act), and such Holder has such experience in business and financial matters that it is capable of evaluating the merits and risks of an investment in the New Securities. Each Holder is not required to be
registered as a broker-dealer under Section 15 of the Exchange Act, and such Holder is not a broker-dealer. Each Holder acknowledges that an investment in the New Securities is speculative and involves a high degree of risk. 
 (f) Each Holder is and will be acquiring its New Securities for its own account, and not with a view to any resale or distribution in whole or in part,
in violation of the Securities Act or any applicable securities laws. Each Holder does not have a present intention to sell any New Securities, nor a present arrangement (whether or not legally binding) or intention to effect any distribution of any
New Securities to or through any person or entity; provided, however, that by making the representations herein, such Holder does not agree to hold New Securities for any minimum or other specific term and reserves the right to dispose
of New Securities at any time in accordance with federal and state securities laws applicable to such disposition. Each Holder acknowledges that it (i) has such knowledge and experience in financial and business matters such that it is capable
of evaluating the merits and risks of its investment in the Company, (ii) is able to bear the financial risks associated with an investment in its New Securities and (iii) has been given full access to such records of the Company and its
subsidiaries and to the officers of the Company and the subsidiaries as it has deemed necessary or appropriate to conduct its due diligence investigation. 
 (g) The offer and sale of the New Securities is intended to be exempt from registration under the Securities Act by virtue of Section 3(a)(9) and/or Section 4(2) thereof. Each Holder understands that its New
Securities have not been, and may never be, registered under the Securities Act and that none of such New Securities can be sold or transferred unless they are first registered under the Securities Act and such state and other securities laws as may

  

 6 

 
be applicable or the Company receives an opinion of counsel reasonably acceptable to the Company that an exemption from registration under the Securities Act
is available (and then such New Securities may be sold or transferred only in compliance with such exemption and all applicable state and other securities laws). Each Holder acknowledges that it is familiar with Rule 144 under the Securities Act
(“Rule 144”) and that such Holder has been advised that Rule 144 permits resales only under certain circumstances. Each Holder understands that to the extent that Rule 144 is not available, such Holder will be unable to sell its New
Securities without either registration under the Securities Act or the existence of another exemption from such registration requirement. 
 (h) Each Holder has not employed any broker or finder or incurred any liability for any brokerage or investment banking fees, commissions, finders’ structuring fees, financial advisory fees or other similar fees in connection with any
of the transactions contemplated by this Agreement. 
 (i) Each Holder acknowledges that no New Securities were offered to it by means of any
form of general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including (i) any advertisement, article, notice or other communication published in any newspaper, magazine or similar
media, or broadcast over television or radio, or (ii) any seminar or meeting to which such Holder was invited by any of the foregoing means of communications. Each Holder, in making the decision to acquire its New Securities, has relied upon
independent investigation made by it and the representations, warranties and agreements set forth in this Agreement and has not relied on any information or representations made by third parties. 
 (j) Each Series A Holder and Series B Holder hereby (i) authorizes and approves the form, terms and provisions of the Series C Certificate of
Designation and the Series D Certificate of Designation and the filing of the Series C Certificate of Designation and the Series D Certificate of Designation by the Company with the Secretary of State of the State of Delaware and (ii) consents
to the authorization, issuance and delivery by the Company of (x) the Series C Preferred Shares and the Series D Preferred Shares pursuant to Section 1(a) hereof and (y) the Series D Preferred Shares issuable under certain
circumstances upon conversion of the Series C Preferred Shares, as described in the Series C Certificate of Designation. 
 (k) Each Holder
covenants that neither it nor any affiliate acting on its behalf or pursuant to any understanding with it will execute any Short Sales (as defined below) during the period commencing on the date hereof and ending upon (i) the expiration of the
Lock-Up Period (as such term is defined in the New Registration Rights Agreement) or (ii) the date that is six (6) months after the date hereof, if a Qualified Offering (as such term is defined in the Series C Certificate of Designation)
has not been consummated by such date. Each Holder covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company, such Holder will maintain the confidentiality of all disclosures made to it
in connection with such transactions (including the existence and terms of such transactions). “Short Sales” shall include all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act 
  

 7 

 3. Representations, Warranties and Covenants of the Company. The Company represents
and warrants to each Holder, and covenants for the benefit of each Holder, as follows: 
 (a) The Company has been duly incorporated and is
validly existing and in good standing under the laws of the State of Delaware, with full corporate power and authority to own, lease and operate its properties and to conduct its business as currently conducted, and is duly registered and qualified
to conduct its business and is in good standing in each jurisdiction or place where the nature of its properties or the conduct of its business requires such registration or qualification, except where the failure to register or qualify or be in
good standing would not have a Material Adverse Effect. For purposes of this Agreement, “Material Adverse Effect” shall mean any material adverse effect on the business, assets, properties, financial condition or results of
operations of the Company and its subsidiaries, taken as a whole, or any condition, circumstance, fact or event that would prohibit or otherwise materially interfere with the ability of the Company to perform any of its obligations under this
Agreement, the Series C Certificate of Designation, the Series D Certificate of Designation and the New Registration Rights Agreement (collectively, the “Transaction Documents”). 
 (b) The New Securities have been duly authorized by all necessary corporate action on the part of the Company and, when issued in accordance with the
terms hereof or the terms of the Series C Certificate of Designation or the Series D Certificate of Designation, the New Securities will be validly issued, fully paid and nonassessable, free and clear of any and all Liens other than as expressly set
forth in the Transaction Documents or those created by any Holder. The shares of Common Stock issuable upon conversion of the Series C Preferred Shares and the Series D Preferred Shares have been duly reserved for issuance by the Company.

 (c) Each of this Agreement and the other Transaction Documents has been duly authorized, validly executed and delivered on behalf of the
Company and is a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to limitations on enforcement by general principles of equity and by bankruptcy or other laws affecting the
enforcement of creditors’ rights generally, and the Company has full power and authority to execute and deliver this Agreement and the other Transaction Documents and to perform its obligations hereunder and thereunder. 
 (d) The execution and delivery by the Company of this Agreement and the other Transaction Documents and the consummation by the Company of the
transactions contemplated by this Agreement and the other Transaction Documents do not and will not (i) conflict with, or result in a breach of or a default (with or without notice or lapse of time or both) under, any of the terms or provisions
of (A) the Company’s certificate of incorporation or bylaws, each as amended to date, or (B) any indenture, mortgage, deed of trust or other agreement or instrument to which the Company or any of its subsidiaries is a party or by
which the Company or any of its subsidiaries, or any of their respective properties or assets, is bound, (ii) result in a violation of any provision of any existing applicable law, statute, rule, regulation, decree, judgment or order of or by
any court, federal or state regulatory body, administrative agency or other governmental body having jurisdiction over the Company or any of its subsidiaries or any of their respective properties or assets or (iii) result in the creation or
imposition of any Lien upon any properties or assets of the Company or any of its subsidiaries 

  

 8 

 
pursuant to the terms of any agreement or instrument to which any of them is a party or by which any of them or their respective properties or assets is
bound, except in the case of clauses (i)(B), (ii) and (iii) for any such conflicts, breaches, defaults, violations or Liens that would not have a Material Adverse Effect. 
 (e) No consent, approval or authorization of, or notice, registration or filing with, any governmental authority on the part of the Company is required
in connection with the execution, delivery and performance of this Agreement or the offer, issuance or delivery of the New Securities or the consummation of any other transaction contemplated by this Agreement or any of the other Transaction
Documents (other than the filing of the Series C Certificate of Designation and the Series D Certificate of Designation with the Secretary of State of the State of Delaware or any filings which may be required to be made by the Company with the
Commission or pursuant to any state or “blue sky” securities laws subsequent to the Closing, including pursuant to the terms of the New Registration Rights Agreement). 
 (f) The authorized capital stock of the Company and the shares thereof issued and outstanding as of June 11, 2007 are set forth on Schedule
3(f) attached hereto. All of the outstanding shares of the Company’s capital stock have been duly and validly authorized and issued, are fully paid and non-assessable, and were not issued in violation of any preemptive rights. 

(g) The Company has made available to the Holders the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006
(the “Form 10-KSB”) filed by the Company with the Commission. The Form 10-KSB (i) was prepared in all material respects in accordance with the requirements of the Exchange Act and (ii) did not at the time it was filed
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Each of
the Company’s financial statements included in the Form 10-KSB (x) present fairly in all material respects the financial position of the Company and its subsidiaries on a consolidated basis as of the dates thereof and their results of
operations, cash flows and stockholders’ equity for each of the periods then ended, and (y) were prepared in accordance with United States generally accepted accounting principles applied on a consistent basis throughout the periods
involved, in each case, except as otherwise indicated in the notes thereto. 
 (h) There is no action, suit or proceeding pending or, to the
knowledge of the Company, threatened against the Company which questions the validity of this Agreement or any of the other Transaction Documents or the transactions contemplated hereby or thereby or any action taken or to be taken pursuant hereto
or thereto. There is no action, suit or proceeding pending or, to the knowledge of the Company, threatened against the Company or any of its subsidiaries, or any of their respective properties or assets, which, if adversely determined, would have a
Material Adverse Effect. 
 (i) Neither the Company nor any of its subsidiaries nor any agent acting on behalf of the Company or any of its
subsidiaries has taken or will take any action which would cause this Agreement or the offer, issuance or delivery of the New Securities to violate the Securities Act or the Exchange Act or any rules or regulations promulgated thereunder, as in

  

 9 

 
effect on the Closing Date. Assuming that all of the representations and warranties of each Holder set forth in Section 2 are true, the offer, issuance
and delivery of the New Securities hereunder is being conducted and completed in compliance with the Securities Act. 
 (j) Except for
Burnham Hill Partners, which, through affiliates, owns securities to be restructured pursuant to the terms provided herein, the Company has not employed any broker or finder or incurred any liability for any brokerage or investment banking fees,
commissions, finders’ structuring fees, financial advisory fees or other similar fees in connection with the transactions contemplated by this Agreement. 
 (i) The Company covenants and agrees that promptly following the Closing, all of the Holders’ Series A Preferred Shares and Series B Preferred Shares will be cancelled and retired, and all of the Holders’ AA
Warrants, BB/C Warrants, BH Warrants and Series B Warrants will be cancelled and terminated, by the Company. 
 4. Conditions
Precedent to the Obligation of the Company to Issue the New Securities. The obligation of the Company to issue and deliver the New Securities to be acquired by each Holder hereunder is subject to the satisfaction or waiver, at or before the
Closing Date, of each of the conditions set forth below. These conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion. 
 (a) A sufficient number of Holders, as determined by the Company in its sole discretion, shall have executed and delivered to the Company this Agreement
and the New Registration Rights Agreement. 
 (b) Each such Holder shall have delivered to the Company for cancellation, retirement and/or
termination all of the Old Securities owned of record or beneficially by such Holder. 
 (c) Each such Holder shall have performed, satisfied
and complied with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Holder at or prior to the Closing Date. 
 (d) The representations and warranties of each such Holder shall be true and correct as of the Closing Date, except for representations and warranties
that are expressly made as of a particular date, which shall continue to be true and correct as of such date. 
 5. Conditions
Precedent to the Obligation of the Holders to Accept the New Securities. The obligation of each Holder to accept the New Securities to be acquired by it hereunder is subject to the satisfaction or waiver, at or before the Closing Date, of
each of the conditions set forth below. These conditions are for each Holder’s sole benefit and may be waived by each Holder at any time in its sole discretion. 
 (a) The Company shall have executed and delivered this Agreement and the New Registration Rights Agreement. 
  

 10 

 (b) The Company shall have filed the Series C Certificate of Designation and the Series D Certificate of
Designation with the Secretary of State of the State of Delaware. 
 (c) The Company shall have performed, satisfied and complied with all
covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by it at or prior to the Closing Date. 
 (d) The representations and warranties of the Company shall be true and correct as of the Closing Date, except for representations and warranties that are expressly made as of a particular date, which shall continue to be true and correct
as of such date. 
 (e) No statute, regulation, order, decree, ruling or injunction shall have been enacted, entered, promulgated or enforced
by any court or governmental authority of competent jurisdiction which prohibits the consummation of the transactions contemplated by this Agreement at or prior to the Closing Date. 
 6. Securities Law Compliance. 
 (a) Securities Act. The Company shall timely prepare and file with the Commission the form of notice of the issuance of the New Securities pursuant to the requirements of Regulation D under the Securities Act. 
 (b) State Securities Law Compliance. The Company shall timely prepare and file such applications, consents to service of process (but not
including a general consent to service of process) and similar documents and take such other steps and perform such further acts as shall be required by the state securities law requirements of each jurisdiction where a Holder resides, as indicated
on each Holder’s signature page hereto, with respect to the issuance of the New Securities under this Agreement; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not
then so qualified or to take any action that would subject it to general service of process in any jurisdiction where it is not then so subject or subject the Company to any material tax in any such jurisdiction where it is not then so subject.

 7. Transfer Restrictions. 
 (a) The New Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of New Securities other than pursuant to an effective registration statement, to the
Company, to an affiliate of a Holder (who is an accredited investor and executes a customary representation letter) or in connection with a pledge as contemplated in Section 7(b), the Company may require the transferor thereof to provide to the
Company an opinion of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that the transfer does not require registration of the transferred New Securities under
the Securities Act; provided, however, that in the case of a transfer pursuant to Rule 144, no opinion shall be required if the transferor provides the Company with a customary seller’s representation letter and, if the sale is not pursuant to
subsection (k) of Rule 144, a customary broker’s representation letter and a Form 144. Any transferee that agrees in writing to be bound by the terms of this Agreement and the 

  

 11 

 
New Registration Rights Agreement shall have the rights of the transferring Holder under this Agreement and, to the extent provided therein, the New
Registration Rights Agreement. Except as required by federal securities laws and the securities law of any state or other jurisdiction within the United States, New Securities may be transferred, in whole or in part, by a Holder to any person at any
time. Upon surrender of certificates evidencing the New Securities being transferred in accordance with this Section 7(a), the Company shall reissue certificates evidencing the New Securities so transferred. 
 (b) Each Holder agrees to the imprinting, so long as is required by this Section 7, of a legend on any of such Holder’s New Securities in
substantially the following form: 
 THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO
THE TRANSFEROR TO THIS EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT. 
 The Company acknowledges and agrees that
each Holder may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of such Holder’s New Securities to a financial institution that is an “accredited
investor” as defined in Rule 501(a) under the Securities Act and, if required under the terms of the arrangement, such Holder may transfer such pledged or secured New Securities to the pledgees or secured parties. Such pledge or transfer would
not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith; provided, however, that such Holder shall provide the Company with the documentation
as is reasonably requested by the Company to ensure that the pledge is pursuant to a bona fide margin agreement with a registered broker-dealer or a security interest in some or all of such Holder’s New Securities to a financial institution
that is an “accredited investor” as defined in Rule 501(a) under the Securities Act. The Company will execute and deliver the documentation as a pledgee or secured party of New Securities may reasonably request in connection with a pledge
or transfer of such New Securities, including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of
selling stockholders thereunder. 
  

 12 

 (c) Certificates evidencing the shares of Common Stock (x) issued upon conversion of the Series C
Preferred Shares and Series D Preferred Shares and (y) issued pursuant to Section 1(a) hereof (such shares of Common Stock, the “New Common Shares”) shall not contain any legend (including the legend set forth in
Section 7(b)) (i) following any sale of the New Common Shares pursuant to Rule 144 or pursuant to an effective registration statement, or (ii) if the New Common Shares are eligible for sale under Rule 144(k), provided that a Holder
shall provide the Company with such information about such shares and such Holder as is reasonably necessary to permit the Company to conclude that such shares are so eligible, or (iii) if the legend is not required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the Staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Company’s transfer agent promptly upon the
occurrence of any of the events in clauses (i), (ii) or (iii) above to effect the removal of the legend hereunder and shall also cause its counsel to issue a “blanket” legal opinion to the Company’s transfer agent promptly
after the Effective Date (as defined in the New Registration Rights Agreement), if required by the Company’s transfer agent, to allow sales pursuant to an effective registration statement, which opinion may be subject to customary
qualifications. The Company agrees that at the time as the legend is no longer required under this Section 7(c), it will, no later than three trading days following the delivery by a Holder to the Company or the Company’s transfer agent of
a certificate representing New Common Shares issued with a restrictive legend, deliver or cause to be delivered to such Holder a certificate representing such New Common Shares that is free from all restrictive and other legends. The Company may not
make any notation on its records or give instructions to any transfer agent of the Company that enlarge the restrictions on transfer set forth in this Section 7. 
 (d) Each Holder agrees that the removal of the restrictive legend from certificates representing New Common Shares as set forth in this Section 7 is predicated upon the Company’s reliance on and such
Holder’s agreement that it will not sell any New Securities or New Common Shares except pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom. 
 8. Amendment of Prior Agreements. The Company and the Holders hereby agree that the following agreements
are hereby amended to provide that each such agreement will terminate, and the Company and the Holders will have no further rights, obligations or liabilities thereunder, effective as of the Closing Date: (i) the Series A Subscription
Agreement; (ii) the Note Purchase Agreement; and (iii) the Series B Investor Rights Agreement. Each Holder agrees that any and all Penalty Shares (as defined in the Series A Subscription Agreement) that were required to have been issued,
and any and all liquidated damages that have been incurred or accrued, through and including the Closing Date pursuant to the terms of the Series A Subscription Agreement or the Series B Investor Rights Agreement are hereby forever waived.

 9. Holder Release. Each Holder hereby releases, acquits and forever discharges the Company, its affiliates, each of
their respective officers, directors, partners, employees, agents, advisors and representatives and their respective successors and assigns (collectively, the “Released Parties”) from any and all liabilities, claims, demands,
actions or causes of action of any kind or nature whatsoever (if there be any), whether absolute or contingent, disputed or undisputed, at law or in equity, or known or unknown, that such Holder now has or has ever had 

  

 13 

 
against any of the Released Parties arising on or prior to the date hereof under or in connection with any of the Prior Transaction Documents, but not under
or in connection with any of the Transaction Documents. Each Holder hereby severally represents and warrants to the Company that it has not transferred or assigned to any person any claim that such Holder ever had or claimed to have against any of
the Released Parties. 
 10. Indemnification. 
 (a) The Company agrees to indemnify and hold harmless the Holders, their respective affiliates, each of their respective officers, directors, partners, employees, agents, advisors and representatives and their
respective successors and assigns from and against any losses, damages or expenses which are caused by or arise out of (i) any breach or default in the performance by the Company of any covenant or agreement made by the Company in this
Agreement or in any of the Transaction Documents; (ii) any breach of warranty or representation made by the Company in this Agreement or in any of the Transaction Documents; and (iii) any and all third party actions, suits, proceedings,
claims, demands, judgments, costs and expenses (including reasonable legal fees and expenses) incident to any of the foregoing. 
 (b) Each
of the Holders, severally and not jointly, agrees to indemnify and hold harmless the Company, its affiliates, each of their respective officers, directors, partners, employees, agents, advisors and representatives and their respective successors and
assigns from and against any losses, damages or expenses which are caused by or arise out of (i) any breach or default in the performance by such Holder of any covenant or agreement made by such Holder in this Agreement or in any of the
Transaction Documents; (ii) any breach of warranty or representation made by such Holder in this Agreement or in any of the Transaction Documents; and (iii) any and all third party actions, suits, proceedings, claims, demands, judgments,
costs and expenses (including reasonable legal fees and expenses) incident to any of the foregoing. 
 11. Notices. Any
and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number specified in this Section prior to 5:00 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number specified in this Section on a day that is not a business day or later than 5:00 p.m. (New York City time) on any business day, or (c) the business day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service such as Federal Express with next day delivery specified. The addresses for such notices and communications shall be as follows: 
 If to a Holder at such Holder’s address set forth under its name on its signature page hereto, or with respect to the Company, addressed to: 
 GlobalOptions Group, Inc. 
 75 Rockefeller
Plaza 
 27th Floor 
 New York, New York 10019 
 Attention: Chief Financial Officer 
 Facsimile No.: 212-445-0053 
  

 14 

 or to such other address or addresses or facsimile number or
numbers as any such party may most recently have designated in writing to the other parties hereto by such notice. Copies of notices to the Company shall be sent to Olshan Grundman Frome Rosenzweig & Wolosky LLP, Park Avenue Tower, 65 East
55th Street, New York, NY 10022, Attn: Robert H. Friedman, Esq., Facsimile No. 212-451-2222. Copies of
notices to a Holder shall be sent to the addresses, if any, listed on such Holder’s signature page hereto. 
 Unless otherwise stated
above, such communications shall be effective when they are received by the addressee thereof in conformity with this Section 11. Any party may change its address for such communications by giving notice thereof to the other parties in
conformity with this Section. 
 12. Governing Law. All questions concerning the construction, validity, enforcement and
interpretation of this Agreement shall be governed by and enforced in accordance with the laws of the State of New York without reference to the conflicts of laws principles thereof. 
 13. Jurisdiction and Venue. This Agreement shall be subject to the exclusive jurisdiction of the Federal District Court, Southern
District of New York and if such court does not have proper jurisdiction, the State Courts of New York County, New York. The parties to this Agreement agree that any breach of any term or condition of this Agreement shall be deemed to be a breach
occurring in the State of New York by virtue of a failure to perform an act required to be performed in the State of New York and irrevocably and expressly agree to submit to the jurisdiction of the Federal District Court, Southern District of New
York and if such court does not have proper jurisdiction, the State Courts of New York County, New York for the purpose of resolving any disputes among the parties relating to this Agreement or the transactions contemplated hereby. The parties
irrevocably waive, to the fullest extent permitted by law, any objection which they may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement, or any judgment entered by any court
in respect hereof brought in New York County, New York, and further irrevocably waive any claim that any suit, action or proceeding brought in Federal District Court, Southern District of New York and if such court does not have proper jurisdiction,
the State Courts of New York County, New York has been brought in an inconvenient forum. Each of the parties hereto consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in
effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section 13 shall affect or limit any right to serve process in any other
manner permitted by law. 
 14. Successors and Assigns. This Agreement is personal to each of the parties and may not be
assigned without the written consent of the other parties; provided, however, that any of the Holders shall be permitted to assign this Agreement to any person to whom it assigns or transfers securities issued or issuable pursuant to this Agreement.
Any assignee must be an “accredited investor” as defined in Rule 501(a) promulgated under the Securities Act. 
 15.
Severability. If any provision of this Agreement, or the application thereof, shall for any reason or to any extent be invalid or unenforceable, the remainder of this Agreement and application of such provision to other persons or
circumstances shall continue in full force and effect and in no way be affected, impaired or invalidated. 
  

 15 

 16. Entire Agreement. This Agreement and the other agreements and instruments
referenced herein constitute the entire understanding and agreement of the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings among the parties hereto. 
 17. Amendment and Waivers. Any term or provision of this Agreement may be amended, and the observance of any term of this Agreement
may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a writing signed by the Company and the holders of at least a majority-in-interest of the Old Securities, and such waiver or amendment, as
the case may be, shall be binding upon all Holders. The waiver by a party of any breach hereof or default in the performance hereof shall not be deemed to constitute a waiver of any other default or any succeeding breach or default. No amendment
shall be effected to impact a Holder in a disproportionately adverse fashion without the consent of such Holder. 
 18. No
Waiver. The failure of any party to enforce any of the provisions hereof shall not be construed to be a waiver of the right of such party thereafter to enforce such provisions. 
 19. No Third Party Beneficiary. Except as expressly set forth in Section 10 hereof, nothing expressed or implied in this
Agreement is intended, or shall be construed, to confer upon or give any person other than the parties hereto and their respective heirs, personal representatives, legal representatives, successors and permitted assigns, any rights or remedies under
or by reason of this Agreement. 
 20. Waiver of Trial by Jury. THE PARTIES HERETO IRREVOCABLY WAIVE TRIAL BY JURY IN
ANY SUIT, ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 
 21. Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an original as against any party whose signature appears thereon and all of which together shall constitute one and the same instrument. This Agreement shall become
binding when one or more counterparts hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon as signatories. In the event that any signature is delivered by facsimile or other electronic image
transmission technology, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof. 

22. Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder under this Agreement or any
Transaction Documents are several and not joint with the obligations of any other Holder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder under any such agreement. Nothing contained herein or
in any Transaction Documents, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption
that the Holders are in any way acting in concert or as a group with respect to such obligations or the transactions 

  

 16 

 
contemplated by such agreement. Each Holder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights
arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. Each Holder represents that it has been represented
by its own separate legal counsel in its review and negotiation of this Agreement and the other Transaction Documents. 
 [THE REMAINDER OF
THIS PAGE IS INTENTIONALLY LEFT BLANK] 
  

 17 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

  

			
	 GLOBALOPTIONS GROUP, INC.

		
	 By:
	 	 /s/ Harvey W. Schiller

	 Name:
	 	 Harvey W. Schiller

	 Title:
	 	 Chairman and Chief Executive Officer

 [COMPANY SIGNATURE PAGE TO RESTRUCTURING AGREEMENT] 
  

 18 

 OMNIBUS SIGNATURE PAGE TO 
 GLOBALOPTIONS GROUP, INC. 
 RESTRUCTURING AGREEMENT 
 AND 
 RESTRUCTURING REGISTRATION
RIGHTS AGREEMENT 
 The undersigned hereby acknowledges that he, she or it has read and understands all of the terms and provisions of
each of the Restructuring Agreement and the Restructuring Registration Rights Agreement, including all exhibits and schedules thereto, and has had the opportunity to consult with legal counsel in connection therewith. By signing below, the
undersigned hereby makes the representations and warranties of the undersigned set forth in, and agrees to be bound by all of the terms and provisions of, each of the Restructuring Agreement and the Restructuring Registration Rights Agreement.

  

					
	 Date:                        , 2007
	 	Print Name (as it appears on your preferred stock or warrant certificate):
			
		 		 	  

			
		 	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

		 	Address:	 	  

		 		 	  

		 		 	  

		 	Telephone:	 	  

		 	Facsimile:	 	  

		 	SSN/EIN#:	 	  

 * Please note that in order for you to receive your Series C Preferred Stock, Series D Preferred Stock and/or
Common Stock pursuant to the terms of the Restructuring Agreement, all of the above information must be completed. You must deliver this properly completed and duly executed signature page, together with all preferred stock and warrant certificates
held by you, in proper form for transfer, or a lost securities affidavit in lieu thereof, to the Company in order to participate in the restructuring. 
  

 19Restructuring Registration Rights Agreement, dated as of July 25, 2007

 Exhibit 10.2 
 RESTRUCTURING REGISTRATION RIGHTS AGREEMENT 
 This Restructuring Registration Rights Agreement (this
“Agreement”) is made and entered into as of July 25, 2007 among GlobalOptions Group, Inc., a Delaware corporation (the “Company”), and each of the investors and other parties executing this Agreement and listed on
Schedule 1 attached hereto (collectively, the “Investors”). 
 This Agreement is being entered into pursuant to the
Restructuring Agreement, dated as of the date hereof, by and among the Company and the Investors (the “Restructuring Agreement”). 
 The Company and the Investors hereby agree as follows: 
  

	 	1.	Definitions. 

 Capitalized terms used and not
otherwise defined herein shall have the meanings given such terms in the Restructuring Agreement. As used in this Agreement, the following terms shall have the following meanings: 
 “Advice” shall have the meaning set forth in Section 3(m). 
 “Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls or is controlled by or under common
control with such Person. For the purposes of this definition, “control,” when used with respect to any Person, means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of such
Person, whether through the ownership of voting securities, by contract or otherwise; and the terms of “affiliated,” “controlling” and “controlled” have meanings correlative to the foregoing. 
 “Blackout Period” shall have the meaning set forth in Section 3(n). 
 “Board” shall have the meaning set forth in Section 3(n). 
 “Business Day” means any day except Saturday, Sunday and any day which shall be a legal holiday or a day on which banking institutions
in the State of New York generally are authorized or required by law or other government actions to close. 
 “Commission”
means the Securities and Exchange Commission. 
 “Common Stock” means the Company’s Common Stock, par value $0.001 per
share. 
 “Conversion Shares” means, without duplication, the shares of Common Stock issued or issuable upon conversion of
the Series C Preferred Stock or the Series D Preferred Stock issued (i) pursuant to Section 1(a) of the Restructuring Agreement or (ii) in the case of the Series D Preferred Stock, upon conversion of the Series C Preferred Stock (in
any such case, without regard to any limitations on beneficial ownership contained in the Series C Certificate of Designation or Series D Certificate of Designation). 

 “Effectiveness Date” means the earlier of (i) the date that is one hundred and
fifty (150) days following the Closing Date, provided that such date shall be tolled for the duration of any Blackout Period, and (ii) the effective date of a registration statement relating to a Qualified Offering (as such term is defined
in the Series C Certificate of Designation). 
 “Effectiveness Period” shall have the meaning set forth in Section 2.

 “Event” shall have the meaning set forth in Section 8(e). 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 “Filing Date” means the earlier of (i) the 90th day following the Closing Date, provided that such date shall be tolled for the duration of any Blackout Period, and
(ii) the filing date of a registration statement relating to a Qualified Offering. 
 “Holder” or
“Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities, including without limitation the Investors and their assignees. 
 “Indemnified Party” shall have the meaning set forth in Section 5(c). 
 “Indemnifying Party” shall have the meaning set forth in Section 5(c). 
 “Losses” shall have the meaning set forth in Section 5(a). 
 “Person” means an individual or a corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind. 
 “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened. 
 “Prospectus” means the prospectus included in any Registration Statement (including, without limitation, a prospectus that includes any
information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by such Registration Statement, and all other amendments and supplements to such Prospectus, including post-effective amendments, and all material incorporated by reference
in such Prospectus. 
 “Registrable Securities” means, without duplication for or in respect of any Series D Shares,
(a) the Conversion Shares and the Restructuring Shares or other securities issued or issuable to each Investor or its transferee or designee (i) upon conversion of the Series C Preferred Stock or the Series D Preferred Stock or
(ii) upon any distribution with respect to, any exchange for or any replacement of Series C Preferred Stock, Series D Preferred Stock, Conversion Shares or Restructuring Shares or (iii) upon any conversion, exercise or 

  

 2 

 
exchange of any securities issued in connection with any such distribution, exchange or replacement; (b) securities issued or issuable upon any stock
split, stock dividend, recapitalization or similar event with respect to the foregoing; and (c) any other security issued as a dividend or other distribution with respect to, in exchange for, in replacement or redemption of, or in reduction of
the liquidation value of, any of the securities referred to in the preceding clauses; provided, however, that such securities shall cease to be Registrable Securities when such securities have been sold to or through a broker or dealer or
underwriter in a public distribution or a public securities transaction or when such securities may be sold without any restriction pursuant to Rule 144(k) as determined by the counsel to the Company pursuant to a written opinion letter, addressed
to the Company’s transfer agent to such effect as described in Section 2 of this Agreement. For purposes of any provision of this Agreement that refers to an amount of Registrable Securities held by any Person, such amount shall be deemed
to include Registrable Securities that such Person has the right to acquire upon conversion or exercise of any securities of the Company held by such Person, without regard to any limitations on beneficial ownership contained in such securities.

 “Registration Statement” means the registration statement and any additional registration statements contemplated by
Section 2(a), 2(b) or 3(b), including (in each case) the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by
reference in such registration statement, but in any such case only to the extent relating to Registrable Securities. 
 “Restructuring Shares” means the shares of Common Stock issued to the Investors pursuant to Section 1(a) of the Restructuring Agreement. 
 “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the
Commission having substantially the same effect as such Rule. 
 “Rule 158” means Rule 158 promulgated by the Commission
pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “Securities Act” means the Securities Act of 1933, as amended. 
 “Series C Preferred Stock” means
the Series C Convertible Preferred Stock of the Company, par value $0.001 per share. 
 “Series D Preferred Stock” means the
Series D Convertible Preferred Stock of the Company, par value $0.001 per share. 
  

 3 

 “Series D Shares” means any Series D Preferred Stock issued or issuable upon conversion
of the Series C Preferred Stock and any shares of Common Stock issued or issuable upon conversion of such Series D Preferred Stock. 
 “Special Counsel” means Kramer Levin Naftalis & Frankel LLP. 
  

	 	2.	Registration. 

 (a) As soon as possible following
the Closing Date (but not later than the Filing Date), the Company shall prepare and file with the Commission a “shelf” Registration Statement covering all Registrable Securities for a secondary or resale offering to be made on a
continuous basis pursuant to Rule 415. The Registration Statement shall be on Form S-3 (or if such form is not available to the Company on another form appropriate for such registration in accordance herewith). The Company shall use its best efforts
to cause the Registration Statement to be declared effective under the Securities Act not later than the Effectiveness Date (including filing with the Commission a request for acceleration of effectiveness in accordance with Rule 461 promulgated
under the Securities Act within five (5) Business Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that a Registration Statement will not be “reviewed,” or not be subject to
further review) and to keep such Registration Statement continuously effective under the Securities Act until such date as is the earlier of (x) the date when all Registrable Securities covered by such Registration Statement have been sold or
(y) with respect to any Holder, such time as all Registrable Securities held by such Holder may be sold without any restriction pursuant to Rule 144(k) as determined by the counsel to the Company pursuant to a written opinion letter, addressed
to the Company’s transfer agent to such effect (the “Effectiveness Period”). For purposes of the obligations of the Company under this Agreement, no Registration Statement shall be considered “effective” with respect
to any Registrable Securities unless such Registration Statement lists the Holders of such Registrable Securities as “Selling Stockholders” and includes such other information as is required to be disclosed with respect to such Holders to
permit them to sell their Registrable Securities pursuant to such Registration Statement, unless any such Holder is not included as a “Selling Stockholder” pursuant to Section 3(m). Such Registration Statement also shall cover, to the
extent allowable under the Securities Act and the rules and regulations promulgated thereunder (including Securities Act Rule 416), such indeterminate number of additional shares of Common Stock resulting from stock splits, stock dividends or
similar transactions with respect to the Registrable Securities. By 9:30 am on the Business Day following the effective date of any Registration Statement, the Company shall file with the Commission in accordance with Rule 424 under the Securities
Act the final prospectus to be used in connection with sales pursuant to such Registration Statement. 
 (b) Notwithstanding anything to the
contrary set forth in this Section 2, in the event the Commission does not permit the Company to register for resale all of the Registrable Securities in the Registration Statement because of the Commission’s application of Rule 415, the
Company shall register in the Registration Statement such number of Registrable Securities as is permitted by the Commission. In the event the Commission does not permit the Company to register for resale all of the Registrable Securities in the
initial Registration Statement, the Company shall use its best efforts to file 

  

 4 

 
subsequent Registration Statements to register for resale the Registrable Securities that were not registered in the initial Registration Statement as
promptly as possible and in a manner permitted by the Commission. For purposes of this Section 2(b), “Filing Date” means with respect to each subsequent Registration Statement filed pursuant hereto, the later of (x) sixty
(60) days following the sale of substantially all of the Registrable Securities included in the initial Registration Statement or any subsequent Registration Statement and (y) six (6) months following the effective date of the initial
Registration Statement or any subsequent Registration Statement, as applicable. For purposes of this Section 2(b), “Effectiveness Date” means with respect to each subsequent Registration Statement filed pursuant hereto, the earlier of
(A) the ninetieth (90th) day following the filing date of such Registration Statement (or in the event such Registration Statement receives a “full review” by the Commission, the one hundred twentieth (120th) day following
such filing date) or (B) the date which is within three (3) Business Days after the date on which the Commission informs the Company (i) that the Commission will not review such Registration Statement or (ii) that the Company may
request the acceleration of the effectiveness of such Registration Statement and the Company makes such request; provided that, if the Effectiveness Date falls on a day that is not a Business Day, the Effectiveness Date shall be the following
Business Day. In the event of a change in circumstance of the Company (e.g., an increase in the Company’s public float) or a change in any rule or regulation of the Commission or interpretation thereof that would permit the filing of a
subsequent Registration Statement prior to the occurrence of the events set forth in clauses (x) and (y) above, the Company shall enter into good faith discussions with the holders of Registrable Securities included in such subsequent
Registration Statement to determine an appropriate filing and effectiveness date for such subsequent Registration Statement. 
  

	 	3.	Registration Procedures. 

 In connection with the
Company’s registration obligations hereunder, the Company shall: 
 (a) Prepare and file with the Commission on or prior to the Filing
Date, a Registration Statement on Form S-3 (or if such form is not available to the Company on another form appropriate for such registration in accordance herewith) (which shall include a Plan of Distribution substantially in the form of Exhibit
A attached hereto), and cause the Registration Statement to become effective and remain effective as provided herein; provided, however, that not less than three (3) Business Days prior to the filing of the Registration Statement or any
related Prospectus or any amendment or supplement thereto, the Company shall (i) furnish to the Special Counsel and the Holders, copies of all such documents proposed to be filed, which documents (other than those incorporated by reference)
will be subject to the review of such Special Counsel and Holders, and (ii) at the request of any Holder cause its officers and directors, counsel and independent certified public accountants to respond to such inquiries as shall be necessary,
in the reasonable opinion of counsel to such Holders, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file the Registration Statement or any such Prospectus or any amendments or supplements
thereto to which the Holders of a majority of the Registrable Securities or the Special Counsel shall reasonably object within three (3) Business Days after their receipt thereof. In the event of any such objection, the Holders shall provide
the Company with any requested revisions to such Prospectus or supplement within two (2) Business Days of such objection. 
  

 5 

 (b)(i) Prepare and file with the Commission such amendments, including post-effective amendments, to the
Registration Statement as may be necessary to keep the Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and to the extent any Registrable Securities are not included in such
Registration Statement for reasons other than the failure of the Holder to comply with Section 3(m) hereof, shall prepare and file with the Commission such amendments to the Registration Statement or such additional Registration Statements in
order to register for resale under the Securities Act all Registrable Securities; (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to
Rule 424 (or any similar provisions then in force) promulgated under the Securities Act; (iii) respond as promptly as possible, and in no event later than ten (10) Business Days to any comments received from the Commission with respect to
the Registration Statement or any amendment thereto and as promptly as reasonably possible provide the Holders true and complete copies of all correspondence from and to the Commission relating to the Registration Statement; and (iv) comply in
all material respects with the provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by the Registration Statement during the applicable period in accordance with the intended
methods of disposition by the Holders thereof set forth in the Registration Statement as so amended or in such Prospectus as so supplemented. 
 (c) Notify Holders of Registrable Securities to be sold and the Special Counsel as promptly as possible (A) when a Prospectus or any Prospectus supplement or post-effective amendment to the Registration Statement is proposed to be
filed (but in no event in the case of this subparagraph (A), less than three (3) Business Days prior to date of such filing); (B) when the Commission notifies the Company whether there will be a “review” of such Registration
Statement and whenever the Commission comments in writing on such Registration Statement; and (C) with respect to the Registration Statement or any post-effective amendment, when the same has become effective, and after the effectiveness
thereof: (i) of any request by the Commission or any other Federal or state governmental authority for amendments or supplements to the Registration Statement or Prospectus or for additional information; (ii) of the issuance by the
Commission of any stop order suspending the effectiveness of the Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iii) of the receipt by the Company of any
notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (iv) if
the financial statements included in the Registration Statement become ineligible for inclusion therein or of the occurrence of any event that makes any statement made in the Registration Statement or Prospectus or any document incorporated or
deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to the Registration Statement, Prospectus or other documents so that, in the case of the Registration Statement or the Prospectus, as the
case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the 

  

 6 

 
statements therein, in the light of the circumstances under which they were made, not misleading. Without limitation to any remedies to which the Holders may
be entitled under this Agreement, if any of the events described in Section 3(c)(C)(i), 3(c)(C)(ii) and 3(c)(C)(iii) occur, the Company shall use its best efforts to respond to and correct the event. 
 (d) Use its best efforts to avoid the issuance of, or, if issued, use best efforts to obtain the withdrawal of, (i) any order suspending the
effectiveness of the Registration Statement or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable time. 
 (e) If requested by any Holder of Registrable Securities, (i) promptly incorporate in a Prospectus supplement or post-effective amendment to the
Registration Statement such information as the Company reasonably agrees should be included therein and (ii) make all required filings of such Prospectus supplement or such post-effective amendment as soon as practicable after the Company has
received notification of the matters to be incorporated in such Prospectus supplement or post-effective amendment. 
 (f) Furnish to each
Holder and the Special Counsel, without charge, at least one conformed copy of each Registration Statement and each amendment thereto, including financial statements and schedules, and all exhibits to the extent requested by such Person (including
those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission. 
 (g) Promptly
deliver to each Holder and the Special Counsel, without charge, as many copies of the Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement thereto as such Persons may reasonably request; and the Company
hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement
thereto. 
 (h) Prior to any public offering of Registrable Securities, use its best efforts to register or qualify or cooperate with the
selling Holders and the Special Counsel in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the securities or Blue Sky laws of such
jurisdictions within the United States as any Holder requests in writing, to keep each such registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things necessary or
advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by a Registration Statement; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it
is not then so qualified or to take any action that would subject it to general service of process in any jurisdiction where it is not then so subject or subject the Company to any material tax in any such jurisdiction where it is not then so
subject. 
 (i) Cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be sold pursuant to a Registration 

  

 7 

 
Statement, which certificates shall be free, to the extent permitted by applicable law and the Restructuring Agreement, of all restrictive legends, and to
enable such Registrable Securities to be in such denominations and registered in such names as any Holder may request at least two (2) Business Days prior to any sale of Registrable Securities. In connection therewith, if required by the
Company’s transfer agent for such purposes, the Company shall promptly after the effectiveness of the Registration Statement cause an opinion of counsel, subject to customary qualifications, to be delivered to and maintained with its transfer
agent, together with any other authorizations, certificates and directions required by the transfer agent, which authorize and direct the transfer agent to issue such Registrable Securities without legend upon sale by the Holder of such shares of
Registrable Securities under the Registration Statement. 
 (j) Following the occurrence of any event contemplated by
Section 3(c)(C)(iv), as promptly as possible, prepare a supplement or amendment, including a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be
incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. 
 (k) Cause all Registrable Securities relating to such Registration Statement to be listed on any United States securities exchange, quotation system, market or over-the-counter bulletin board, if any, on which similar
securities issued by the Company are then listed. 
 (l) Comply in all material respects with all applicable rules and regulations of the
Commission and make generally available to its security holders earnings statements satisfying the provisions of Section 11(a) of the Securities Act and Rule 158 not later than 45 days after the end of any 3-month period (or 90 days after the
end of any 12-month period if such period is a fiscal year) commencing on the first day of the first fiscal quarter of the Company after the effective date of the Registration Statement, which statement shall conform to the requirements of Rule 158.

 (m) Request each selling Holder to furnish to the Company information regarding such Holder and the distribution of such Registrable
Securities as is required by law or the Commission to be disclosed in the Registration Statement, and the Company may exclude from such registration the Registrable Securities of any such Holder who fails to furnish such information within a
reasonable time prior to the filing of each Registration Statement, supplemented Prospectus and/or amended Registration Statement. 
 If the
Registration Statement refers to any Holder by name or otherwise as the holder of any securities of the Company, then such Holder shall have the right to require (if such reference to such Holder by name or otherwise is not required by the
Securities Act or any similar federal statute then in force) the deletion of the reference to such Holder in any amendment or supplement to the Registration Statement filed or prepared subsequent to the time that such reference ceases to be
required. 
  

 8 

 Each Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(c)(C)(i), 3(c)(C)(ii), 3(c)(C)(iii), 3(c)(C)(iv), or 3(n), such Holder will forthwith discontinue disposition of such Registrable Securities under the Registration
Statement until such Holder’s receipt of the copies of the supplemented Prospectus and/or amended Registration Statement contemplated by Section 3(j), or until it is advised in writing (the “Advice”) by the Company that
the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or Registration Statement.

 (n) If (i) there is material non-public information regarding the Company which the Company’s Board of Directors (the
“Board”) reasonably determines not to be in the Company’s best interest to disclose and which the Company is not otherwise required to disclose, or (ii) there is a significant business opportunity (including, but not
limited to, the acquisition or disposition of assets (other than in the ordinary course of business) or any merger, consolidation, tender offer or other similar transaction) available to the Company which the Board reasonably determines not to be in
the Company’s best interest to disclose and which the Company would be required to disclose under the Registration Statement, then the Company may postpone or suspend filing or effectiveness of a Registration Statement for a period not to
exceed 30 consecutive days, provided that the Company may not postpone or suspend its obligation under this Section 3(n) for more than 60 days in the aggregate during any 12 month period (each, a “Blackout Period”). 

 

	 	4.	Registration Expenses. 

 All fees and expenses
incident to the performance of or compliance with this Agreement by the Company shall be borne by the Company whether or not the Registration Statement is filed or becomes effective and whether or not any Registrable Securities are sold pursuant to
the Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings
required to be made with any securities exchange, quotation system, market or over-the-counter bulletin board on which Registrable Securities are required hereunder to be listed, (B) with respect to filings required to be made with the
Commission, and (C) in compliance with state securities or Blue Sky laws (including, without limitation, reasonable and documented fees and disbursements of Special Counsel in connection with Blue Sky qualifications of the Registrable
Securities and determination of the eligibility of the Registrable Securities for investment under the laws of such jurisdictions as the Holders of a majority of Registrable Securities may designate)), (ii) printing expenses (including, without
limitation, expenses of printing certificates for Registrable Securities and of printing or photocopying Prospectuses), (iii) messenger, telephone and delivery expenses, (iv) Securities Act liability insurance, if the Company so desires
such insurance, (v) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement, including, without limitation, the Company’s independent public
accountants (including, in the case of an underwritten offering, the expenses of any comfort letters or costs associated with the delivery by independent public accountants of a comfort letter or 

  

 9 

 
comfort letters) and legal counsel, and (vi) reasonable and documented fees and expenses of the Special Counsel (not to exceed $10,000) in connection
with any Registration Statement hereunder. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation,
all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit, the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange
as required hereunder. The Holders shall be responsible for all underwriting discounts and commissions incurred in connection with such Holders’ sales of Registrable Securities. 
  

	 	5.	Indemnification. 

 (a) Indemnification by the
Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a
result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act) and the officers, directors, agents and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs
(including, without limitation, costs of preparation and reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to any untrue or alleged untrue statement of a material fact
contained or incorporated by reference in the Registration Statement, any Prospectus or any form of Prospectus or in any amendment or supplement thereto or in any preliminary Prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of Prospectus or amendment or supplement thereto, in the light of the circumstances under which they were
made) not misleading, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use
therein, which information was reasonably relied on by the Company for use therein or to the extent that such information relates to (x) such Holder and was reviewed and expressly approved in writing by such Holder expressly for use in the
Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto or (y) such Holder’s proposed method of distribution of Registrable Securities as set forth in Exhibit A (or as such Holder
otherwise informs the Company in writing); or (ii) in the case of an occurrence of an event of the type described in Section 3(c)(C)(ii), 3(c)(C)(iii), 3(c)(C)(iv) or 3(n), the use by a Holder of an outdated or defective Prospectus after
the delivery to the Holder of written notice from the Company that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated in Section 3(m); provided, however, that the indemnity agreement
contained in this Section 5(a) shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld. The Company shall
notify the Holders promptly of the institution, threat or assertion of any Proceeding of which the Company is aware in connection with the transactions contemplated by this Agreement. 

  

 10 

 
Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an Indemnified Party (as defined in
Section 5(c) to this Agreement) and shall survive the transfer of the Registrable Securities by the Holders. 
 (b) Indemnification
by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act
and Section 20 of the Exchange Act), and the directors, officers, agents and employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising solely out of or based
solely upon any untrue statement of a material fact contained in the Registration Statement, any Prospectus, or any form of Prospectus, or in any amendment or supplement thereto, or arising solely out of or based solely upon any omission of a
material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of Prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, to the
extent, but only to the extent, that (i) such untrue statement or omission is contained in or omitted from any information so furnished in writing by such Holder to the Company specifically for inclusion in the Registration Statement or such
Prospectus and that such information was reasonably relied upon by the Company for use in the Registration Statement, such Prospectus, or in any amendment or supplement thereto, or to the extent that such information relates to (x) such Holder
and was reviewed and expressly approved in writing by such Holder expressly for use in the Registration Statement, such Prospectus, or such form of Prospectus or in any amendment or supplement thereto or (y) such Holder’s proposed method
of distribution of Registrable Securities as set forth in Exhibit A (or as such Holder otherwise informs the Company in writing) or (ii) in the case of an occurrence of an event of the type described in Section 3(c)(C)(ii),
3(c)(C)(iii), 3(c)(C)(iv) or 3(n), the use by a Holder of an outdated or defective Prospectus after the delivery to the Holder of written notice from the Company that the Prospectus is outdated or defective and prior to the receipt by such Holder of
the Advice contemplated in Section 3(m) but only if and to the extent that following the receipt of the Advice or the amended or supplemented Prospectus the misstatement or omission giving rise to such Loss would have been corrected; provided,
however, that the indemnity agreement contained in this Section 5(b) shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the prior written consent of the Holder, which consent shall not be
unreasonably withheld. Notwithstanding anything to the contrary contained herein, the Holder shall be liable under this Section 5(b) for only that amount as does not exceed the net proceeds to such Holder as a result of the sale of Registrable
Securities pursuant to such Registration Statement. 
 (c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought
or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party promptly shall notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing,
and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable fees and expenses incurred in connection with
defense thereof; provided, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally
determined by a 

  

 11 

 
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have proximately and materially
adversely prejudiced the Indemnifying Party. 
 An Indemnified Party shall have the right to employ separate counsel in any such Proceeding
and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; or
(2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such
Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not
have the right to assume the defense thereof and such counsel shall be at the reasonable expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent,
which consent shall not be unreasonably withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless
such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding and does not impose any monetary or other obligation or restriction on the Indemnified Party.

 All reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection
with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten (10) Business Days of written notice thereof to the Indemnifying Party,
which notice shall be delivered no more frequently than on a monthly basis (regardless of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder; provided, that the Indemnifying Party may require
such Indemnified Party to undertake to reimburse all such fees and expenses to the extent it is finally judicially determined that such Indemnified Party is not entitled to indemnification hereunder). 
 (d) Contribution. If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party because of a failure or
refusal of a governmental authority to enforce such indemnification in accordance with its terms (by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount
paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that
resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue or 

  

 12 

 
alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied
by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of
any Losses shall be deemed to include, subject to the limitations set forth in Section 5(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms. Notwithstanding anything to the contrary contained herein, the Holder shall be
required to contribute under this Section 5(d) for only that amount as does not exceed the net proceeds to such Holder as a result of the sale of Registrable Securities pursuant to such Registration Statement. 
 The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. No Person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 
 The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties. The indemnity and contribution agreements herein
are in addition to and not in diminution or limitation of any indemnification provisions under the Restructuring Agreement. 
  

	 	6.	Rule 144. 

 As long as any Holder owns Series C
Preferred Stock, Series D Preferred Stock, Conversion Shares or Restructuring Shares, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the
Company after the date hereof pursuant to Section 13(a) or 15(d) of the Exchange Act. As long as any Holder owns Series C Preferred Stock, Series D Preferred Stock, Conversion Shares or Restructuring Shares, if the Company is not required to
file reports pursuant to Section 13(a) or 15(d) of the Exchange Act, it will prepare and furnish to the Holders and make publicly available in accordance with Rule 144(c) promulgated under the Securities Act annual and quarterly financial
statements, together with a discussion and analysis of such financial statements in form and substance substantially similar to those that would otherwise be required to be included in reports required by Section 13(a) or 15(d) of the Exchange
Act, as well as any other information required thereby, in the time period that such filings would have been required to have been made under the Exchange Act. The Company further covenants that it will take such further action as any Holder may
reasonably request, all to the extent required from time to time to enable such Person to sell Series C Preferred Stock, Series D Preferred Stock, Conversion Shares or Restructuring Shares without registration under the Securities Act within the
limitation of the exemptions provided by Rule 144 promulgated under the Securities Act, including compliance with the provisions of the Restructuring Agreement relating to the transfer of the Series C Preferred Stock, Series D Preferred Stock,
Conversion Shares or Restructuring Shares. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements. 
  

 13 

	 	7.	Lock-Up Agreement. 

 (a) Each Holder agrees that,
during the period beginning on the date of the final prospectus covering the first Qualified Offering after the date hereof and continuing to and including the date ninety (90) days after the date of the final prospectus covering such Qualified
Offering (the “Lock-Up Period”), such Holder will not offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of any shares of Common Stock, or any options or warrants to
purchase any shares of Common Stock, or any securities convertible into, exchangeable for or that represent the right to receive shares of Common Stock, whether now owned or hereinafter acquired, owned directly by such Holder (including holding as a
custodian) or with respect to which such Holder has beneficial ownership within the rules and regulations of the Commission (all such shares of Common Stock and other securities of each Holder are collectively referred to as such Holder’s
“Lock-Up Shares”), provided, however, that nothing in this Section 7 shall prevent a Holder’s Lock-Up Shares from being held, in the ordinary course of such Holder’s business, in a custodial account subject to a
blanket security interest or from being disposed of by the custodian pursuant to the terms of such account, provided that such account was not opened for the specific purpose of holding Lock-Up Shares. 
 (b) The foregoing restriction is expressly agreed to preclude each Holder, during the Lock-Up Period, from engaging in any hedging or other transaction
which is designed to or reasonably expected to lead to, or result in, a sale or disposition of such Holder’s Lock-Up Shares even if such shares would be disposed of by someone other than such Holder. Such prohibited hedging or other
transactions would include without limitation any short sale (whether or not against the box) or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to any of such Holder’s Lock-Up Shares
or with respect to any security that includes, relates to, or derives any significant part of its value from such shares. Notwithstanding the foregoing, nothing in this Section 7 shall prohibit (i) any grant or exercise of options to
purchase Common Stock pursuant to the Company’s option plans or (ii) the conversion of any equity security held by such Holder into Common Stock. 
 (c) Notwithstanding the foregoing, during the Lock-Up Period, a Holder may transfer such Holder’s Lock-Up Shares (i) as a bona fide gift or gifts, or by will or intestacy, provided that the transferee or
transferees thereof agree to be bound by the restrictions set forth in this Section 7, (ii) to any trust for the direct or indirect benefit of such Holder or any immediate family member of such Holder, provided that the trustee of the
trust agrees to be bound by the restrictions set forth in this Section 7, and provided further that any such transfer shall not involve a disposition for value unless such disposition for value (x) fully complies with applicable law
(including but not limited to Section 16 under the Exchange Act (“Section 16”) or Rule 144, and the rules and regulations promulgated under each) and (y) is not required to be disclosed or reported under Section 16,
Rule 144 or the rules and regulations promulgated under each, (iii) to any immediate family member or Affiliate of such Holder, provided that the transferee or transferees thereof agree to be bound by the 

  

 14 

 
restrictions set forth in this Section 7, and provided further that any such transfer shall not involve a disposition for value unless such disposition
for value (x) fully complies with applicable law (including Section 16 or Rule 144, and the rules and regulations promulgated under each) and (y) is not required to be disclosed or reported under Section 16, Rule 144 or the rules
and regulations promulgated under each, or (iv) with the prior written consent of the managing underwriter of the Qualified Offering (the “Managing Underwriter”). For purposes of this Section 7, “immediate
family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin. 
 (d) Each Holder severally
represents, as to itself only, that it now has, and, with respect to any Lock-Up Shares held by such Holder at the commencement of the Lock-Up Period, except as contemplated by clauses (i) through (iv) of the foregoing paragraph, for the
duration of such Lock-Up Period will have, good and marketable title to such Holder’s Lock-Up Shares, free and clear of all liens, encumbrances and claims whatsoever, except as contemplated in Section 7(a) hereof. Each Holder also agrees
and consents to the Company entering stop transfer instructions with its transfer agent and registrar against the transfer during the Lock-Up Period of such Holder’s Lock-Up Shares except in compliance with the foregoing restrictions.

 (e) Notwithstanding anything contained in this Section 7 to the contrary, if (1) during the last 17 days of the Lock-Up Period,
the Company issues an earnings release or material news or a material event relating to the Company occurs; or (2) prior to the expiration of the Lock-Up Period, the Company announces that it will release earnings results during the 16-day
period beginning on the last day of the Lock-Up Period, and the Company duly notifies each Holder that an event described in clause (1) or (2) has occurred, then the restrictions imposed by this Section 7 shall continue to apply until
the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event, unless the Managing Underwriter waives, in writing, such extension. 
 (f) Each Holder further severally represents and agrees, as to itself only, that such Holder has not taken and will not take, directly or indirectly, any
action which is designed to or which has constituted or which would reasonably be expected to cause or result in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock, or which
has otherwise constituted or will constitute any prohibited bid for or purchase of the Common Stock or any related securities. 
 (g)
Notwithstanding anything contained in this Section 7 to the contrary, the restrictions in this Section 7 shall terminate and be of no further force or effect upon the earlier of (i) expiration of the Lock-Up Period and
(ii) written notice either by the Company to the Managing Underwriter or by the Managing Underwriter to the Company that the Qualified Offering has been terminated or suspended. 
 (h) Each Holder understands that the Company and the Managing Underwriter will rely upon the agreements set forth in this Section 7 in proceeding
toward consummation of a Qualified Offering. Each Holder further understands that the agreements set forth in this Section 7 are irrevocable, except as otherwise provided in this Section 7, and shall be binding upon such Holder’s
heirs, legal representatives, successors and assigns. 
  

 15 

 (i) Notwithstanding anything contained in this Agreement to the contrary, each Holder agrees that the
Managing Underwriter shall be an express third-party beneficiary of the provisions of this Section 7. 
  

	 	8.	Miscellaneous. 

 (a) Remedies. In the event
of a breach by the Company or by a Holder, of any of their obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including
recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of
any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate. 
 (b) No Inconsistent Agreements. Except as otherwise disclosed in the Restructuring Agreement or in connection with a Qualified Offering or one or
more offerings, consummated within 60 days of the date hereof, of up to $10,000,000 in aggregate principal amount of debt securities of the Company, neither the Company nor any of its subsidiaries is a party to an agreement currently in effect, nor
shall the Company or any of its subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with
the provisions hereof. Without limiting the generality of the foregoing, except as otherwise provided above, without the written consent of the Holders of a majority of the then outstanding Registrable Securities, the Company shall not grant to any
Person the right to request the Company to register any securities of the Company under the Securities Act unless the rights so granted are subject in all respects to the rights of the Holders set forth herein, and are not otherwise in conflict with
the provisions of this Agreement. 
 (c) Notice of Effectiveness. Within two (2) Business Days after the Registration Statement
which includes the Registrable Securities is ordered effective by the Commission, the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies to the Holders
whose Registrable Securities are included in such Registration Statement) confirmation that the Registration Statement has been declared effective by the Commission in the form attached hereto as Exhibit B. 
 (d) Failure to File Registration Statement and Other Events. The Company and the Holders agree that the Holders will suffer damages if a
Registration Statement is not filed on or prior to the Filing Date and maintained in the manner contemplated herein during the Effectiveness Period. The Company and the Holders further agree that it would not be feasible to ascertain the extent of
such damages with precision. Accordingly, if (i) a Registration Statement is not filed on or prior to the Filing Date, or (ii) the Company fails to 

  

 16 

 
file with the Commission a request for acceleration in accordance with Rule 461 promulgated under the Securities Act within five (5) Business Days of
the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that a Registration Statement will not be “reviewed,” or not subject to further review, or (iii) the Company fails to respond to
comments from the Commission with regard to a Registration Statement within thirty (30) days of receipt thereof, or (iv) a Registration Statement is filed with and declared effective by the Commission but thereafter ceases to be effective
as to all Registrable Securities at any time prior to the expiration of the Effectiveness Period, without being succeeded immediately by a subsequent Registration Statement filed with the Commission, except as otherwise permitted pursuant to
Section 3(n), or (v) trading in the Common Stock shall be suspended or if the Common Stock is delisted from any securities exchange, quotation system, market or over-the-counter bulletin board on which Registrable Securities are required
hereunder to be listed (each an “Exchange”), without immediately being listed on any other Exchange, for any reason for more than one (1) Business Day, other than pursuant to Section 3(n) (any such failure or breach being
referred to as an “Event”), the Company shall pay in cash as liquidated damages for such failure and not as a penalty to each Holder an amount equal to (as applicable) (A) in the case of an Event as described in clause
(i) above (and only such an Event), two percent (2%) of such Holder’s Aggregate Share Value (as defined below) (which shall be payable one time only with respect to the occurrence or continued occurrence of an Event pursuant to clause
(i) above) (the “Fixed Amount”) and (B) in the case of any Event, one and one-half percent (1.5%) of such Holder’s Aggregate Share Value for each thirty (30) day period following the occurrence of the Event
until the applicable Event has been cured which shall be pro rated for such periods less than thirty days (the “Periodic Amount”). Payments to be made pursuant to this Section 8(d) shall be due and payable immediately upon
demand in immediately available cash funds. The parties agree that the Fixed Amount and the Periodic Amount represent a reasonable estimate on the part of the parties, as of the date of this Agreement, of the amount of damages that may be incurred
by the Holders if a Registration Statement is not filed on or prior to the Filing Date and maintained in the manner contemplated herein during the Effectiveness Period or if any other Event as described herein has occurred. Notwithstanding the
foregoing, the Company shall remain obligated to cure the breach or correct the condition that caused the Event, and the Holder shall have the right to take any action necessary or desirable to enforce such obligation. “Aggregate Share
Value” shall mean the sum of (i) the aggregate Liquidation Preference (as defined in the Series C Certificate of Designation) of the shares of Series C Preferred Stock acquired by the applicable Investor pursuant to the Restructuring
Agreement and (ii) the product of (x) the number of Restructuring Shares acquired, or acquirable on the Closing Date (without regard to any limitations on beneficial ownership contained in the Series D Certificate of Designation) upon
conversion of the shares of Series D Preferred Stock acquired, by the applicable Investor pursuant to the Restructuring Agreement and (y) the average of the closing bid prices of the Common Stock for the five trading days immediately preceding
the Closing Date. A Periodic Amount shall not accrue or be payable pursuant to this Section 8(d) with respect to more than one Event outstanding at any time. 
 (e) Failure of Registration Statement to Become Effective. The Company and the Holders agree that the Holders will suffer damages if a Registration Statement is not declared effective on or prior to the
Effectiveness Date. The Company and the Holders 

  

 17 

 
further agree that it would not be feasible to ascertain the extent of such damages with precision. Accordingly, if a Registration Statement is not declared
effective on or prior to the Effectiveness Date, the Company shall pay in cash as liquidated damages for such failure and not as a penalty to each Holder an amount equal to (i) two percent (2%) of such Holder’s Aggregate Share Value
upon the occurrence of such failure to be declared effective (the “Effectiveness Fixed Amount”) and (ii) one and one-half percent (1.5%) of such Holder’s Aggregate Share Value for each subsequent thirty (30) day
period (which shall be pro rated for such periods less than thirty (30) days) until the Registration Statement is declared effective (the “Effectiveness Periodic Amount”). Payments to be made pursuant to this Section 8(e)
shall be due and payable immediately upon demand in immediately available cash funds. The parties agree that the Effectiveness Fixed Amount and the Effectiveness Periodic Amount set forth in this Section 8(e) represent a reasonable estimate on
the part of the parties, as of the date of this Agreement, of the amount of damages that may be incurred by the Holders if a Registration Statement is not declared effective on or prior to the Effectiveness Date. At any time that amounts continue to
accrue pursuant to Section 8(d), such amounts shall be credited against any amounts that simultaneously accrue pursuant to this Section 8(e) such that the Company shall in no event be obligated to make any payments under this
Section 8(e) with respect to any period for which it is obligated to pay the Periodic Amount under Section 8(d). The Company shall not be required to pay the Periodic Amount or the Effectiveness Periodic Amount if the Company has
previously paid any such amounts with respect to a period or periods that equal eight (8) months in the aggregate. Notwithstanding the foregoing, the Company shall remain obligated to cause the Registration Statement to become effective, and
the Holders shall have the right to take any action necessary or desirable to enforce this obligation. 
 (f) Rule 415.
Notwithstanding anything herein to the contrary, in the event the Commission does not permit the Company to register for resale all of the Registrable Securities in a Registration Statement because of the Commission’s application of Rule 415
(such Registrable Securities, the “Non-Registered Securities”), none of the Fixed Amount, the Periodic Amount, the Effectiveness Fixed Amount and the Effectiveness Periodic Amount shall be applicable to such Non-Registered
Securities; provided, however, that the Company’s failure to meet the Filing Date and Effectiveness Date as set forth in Section 2(b) for any subsequent Registration Statement filed pursuant to such Section shall subject it
to the liquidated damages provisions set forth in Sections 8(d) and (e), but applying the definitions of Filing Date and Effectiveness Date set forth in Section 2(b). 
 (g) Specific Enforcement, Consent to Jurisdiction. 
 (i) The Company and the Holders acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were
otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement and to enforce specifically the terms and provisions hereof, this being
in addition to any other remedy to which any of them may be entitled by law or equity. 
 (ii) Each of the Company and the
Holders (i) hereby irrevocably submits 

  

 18 

 
to the exclusive jurisdiction of the state and federal courts located in New York City, New York for the purposes of any suit, action or proceeding arising
out of or relating to this Agreement and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is
brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper. Each of the Company and the Holders consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at
the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section 8(g) shall affect or limit any right to serve process
in any other manner permitted by law. 
 (h) Amendments and Waivers. The provisions of this Agreement, including the provisions of
this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of at least a majority of
the Registrable Securities. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders and that does not directly or indirectly affect the rights
of other Holders may be given by Holders of the Registrable Securities to which such waiver or consent relates; provided, however, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the
provisions of the immediately preceding sentence. No amendment shall be effected to impact a Holder in a disproportionately adverse fashion without the consent of such individual Holder. No consideration shall be offered or paid to any person
(i) to amend or consent to a waiver or modification of any provision hereof or of the Series C Certificate of Designation or the Series D Certificate of Designation or (ii) to cause such person to give its consent pursuant to the terms
hereof or of the Series C Certificate of Designation or Series D Certificate of Designation unless, in each case, the same consideration is also offered to all of the parties hereto or holders of Series C Preferred Stock or Series D Preferred Stock,
as the case may be. 
 (i) Notices. Any and all notices or other communications or deliveries required or permitted to be provided
hereunder shall be in writing and shall be deemed given and effective on the earlier of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile telephone number specified for notice prior to
5:00 p.m., New York City time, on a Business Day, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that is not a
Business Day or later than 5:00 p.m., New York City time, on any date and earlier than 11:59 p.m., New York City time, on such date, (iii) the Business Day following the date of mailing, if sent by nationally recognized overnight courier
service such as Federal Express with next day delivery specified or (iv) actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be with respect to each Holder at its address set
forth under its name on Schedule 1 attached hereto, or with respect to the Company, addressed to: 
  

 19 

 GlobalOptions Group, Inc. 
 75 Rockefeller Plaza, 27th Floor 
 New York, NY 10019 
 Attention: President 
 Facsimile No.:
212-445-0053 
 or to such other address or addresses or facsimile number or numbers as any such party may most recently have designated in writing to the
other parties hereto by such notice. Copies of notices to the Company shall be sent to: 
 Olshan Grundman Frome Rosenzweig &
Wolosky LLP 
 Park Avenue Tower 
 65 East 55th Street 
 New York, New York 10022 
 Attention: Robert H. Friedman, Esq. 
 Facsimile No.: 212-451-2222 
 Copies of notices to any Holder shall be sent to the addresses, if any, listed on Schedule 1 attached hereto.

 (j) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns and shall inure to the benefit of each Holder and its successors and permitted assigns; provided, that the Company may not assign this Agreement or any of its rights or obligations hereunder without the prior written consent of
each Holder; and provided, further, that each Holder may assign its rights hereunder in the manner and to the Persons as permitted under the Restructuring Agreement. 
 (k) Assignment of Registration Rights. The rights of each Holder hereunder, including the right to have the Company register for resale Registrable Securities in accordance with the terms of this Agreement,
shall be automatically assignable by each Holder to any transferee of such Holder of all or a portion of the Series C Preferred Stock, the Series D Preferred Stock, the Conversion Shares, the Restructuring Shares or the Registrable Securities if:
(i) the Holder agrees in writing with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the Company within a reasonable time after such assignment, (ii) the Company is, within a reasonable time
after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned,
(iii) following such transfer or assignment the further disposition of such securities by the transferee or assignees is restricted under the Securities Act and applicable state securities laws, (iv) at or before the time the Company
receives the written notice contemplated by clause (ii) of this Section 8(k), the transferee or assignee agrees in writing with the Company to be bound by all of the provisions of this Agreement, and (v) such transfer shall have been
made in accordance with the applicable requirements of the Restructuring Agreement. The rights to assignment shall apply to the Holders (and to subsequent) successors and assigns. 
 The Company may require, as a condition of allowing such assignment in connection 

  

 20 

 
with a transfer of Series C Preferred Stock, the Series D Preferred Stock, the Conversion Shares, the Restructuring Shares or the Registrable Securities
(i) that the Holder or transferee of all or a portion of the Series C Preferred Stock, the Series D Preferred Stock, the Conversion Shares, the Restructuring Shares or the Registrable Securities, as the case may be, furnish to the Company a
written opinion of counsel that is reasonably acceptable to the Company to the effect that such transfer may be made without registration under the Securities Act, (ii) that the Holder or transferee execute and deliver to the Company an
investment letter in form and substance acceptable to the Company and (iii) that the transferee be an “accredited investor” as defined in Rule 501(a) promulgated under the Securities Act. 
 (l) Counterparts; Facsimile. This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an
original and, all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by electronic means or facsimile transmission, such signature shall create a valid binding obligation of the party
executing (or on whose behalf such signature is executed) the same with the same force and effect as if such signature were the original thereof. 
 (m) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to principles of conflicts of law thereof. 
 (n) Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law. 
 (o) Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid,
illegal, void or unenforceable in any respect, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto
shall use their reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the
intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. 
 (p) Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof. 
 (q) Registrable Securities Held by the Company and its Affiliates. Whenever the consent or approval
of Holders of a specified percentage of Registrable Securities is required hereunder, Registrable Securities held by the Company or its Affiliates (other than any Holder or transferees or successors or assigns thereof if such Holder is deemed to be
an Affiliate solely by reason of its holdings of such Registrable Securities) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage. 
  

 21 

 (r) Obligations of Investors. The Company acknowledges that the obligations of each Investor under
this Agreement are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under this Agreement. The decision of each Investor to
enter into to this Agreement has been made by such Investor independently of any other Investor. The Company further acknowledges that nothing contained in this Agreement, and no action taken by any Investor pursuant hereto, shall be deemed to
constitute the Investors as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the
transactions contemplated hereby. Each Investor shall be entitled to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be
joined as an additional party in any proceeding for such purpose. 
 Each Investor has been represented by its own separate legal counsel in
its review and negotiation of this Agreement and with respect to the transactions contemplated hereby. For reasons of administrative convenience only, the Special Counsel will perform certain duties under this Agreement. Such counsel does not
represent all of the Investors. The Company has elected to provide all Investors with the same terms and Agreement for the convenience of the Company and not because it was required or requested to do so by the Investors. The Company acknowledges
that such procedure with respect to this Agreement in no way creates a presumption that the Investors are in any way acting in concert or as a group with respect to this Agreement or the transactions contemplated hereby or thereby. 
 [signature page follows] 
  

 22 

 IN WITNESS WHEREOF, the parties hereto have caused this Restructuring Registration Rights Agreement to be
duly executed by their respective authorized persons as of the date first indicated above. 
  

			
	 COMPANY:

	
	 GLOBALOPTIONS GROUP, INC.

		
	 By:
	 	 /s/ Harvey W. Schiller

	 Name:
	 	 Harvey W. Schiller, Ph.D.

	 Title:
	 	 Chairman and Chief Executive Officer

  

 23 

 OMNIBUS SIGNATURE PAGE TO 
 GLOBALOPTIONS GROUP, INC. 
 RESTRUCTURING AGREEMENT 
 AND 
 RESTRUCTURING REGISTRATION
RIGHTS AGREEMENT 
 The undersigned hereby acknowledges that he, she or it has read and understands all of the terms and provisions of
each of the Restructuring Agreement and the Restructuring Registration Rights Agreement, including all exhibits and schedules thereto, and has had the opportunity to consult with legal counsel in connection therewith. By signing below, the
undersigned hereby makes the representations and warranties of the undersigned set forth in, and agrees to be bound by all of the terms and provisions of, each of the Restructuring Agreement and the Restructuring Registration Rights Agreement.

  

							
	 Date:                    ,
2007
	  	 Print Name (as it appears on your preferred stock or warrant certificate):

				
		  		 	  
	 	
				
		  	By:	 	  
	 	
		  	Name:	 	  
	 	
		  	Title:	 	  
	 	
		  	Address:	 	  
	 	
		  		 	  
	 	
		  		 	  
	 	
		  	Telephone:	 	  
	 	
		  	Facsimile:	 	  
	 	
		  	SSN/EIN#:	 	  
	 	

 * Please note that in order for you to receive your Series C Preferred Stock, Series D Preferred Stock and/or
Common Stock pursuant to the terms of the Restructuring Agreement, all of the above information must be completed. You must deliver this properly completed and duly executed signature page, together with all preferred stock and warrant certificates
held by you, in proper form for transfer, or a lost securities affidavit in lieu thereof, to the Company in order to participate in the restructuring. 
  

 24 

 EXHIBIT A 
 PLAN OF DISTRIBUTION 
 We are registering the shares of common stock on behalf of the selling security
holders. Sales of shares may be made by selling security holders, including their respective donees, transferees, pledgees or other successors-in-interest directly to purchasers or to or through underwriters, broker-dealers or through agents. Sales
may be made from time to time on the OTC Bulletin Board, any other exchange or market upon which our shares may trade in the future, in the over-the-counter market or otherwise, at market prices prevailing at the time of sale, at prices related to
market prices, or at negotiated or fixed prices. The shares may be sold by one or more of, or a combination of, the following: 
  

	•	 	 a block trade in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to
facilitate the transaction (including crosses in which the same broker acts as agent for both sides of the transaction); 

  

	•	 	 purchases by a broker-dealer as principal and resale by such broker-dealer, including resales for its account, pursuant to this prospectus;

  

	•	 	 ordinary brokerage transactions and transactions in which the broker solicits purchases; 

  

	•	 	 through options, swaps or derivatives; 

  

	•	 	 in privately negotiated transactions; 

  

	•	 	 in making short sales or in transactions to cover short sales; 

  

	•	 	 put or call option transactions relating to the shares; and 

  

	•	 	 by any other method permitted by applicable law. 

 The selling security holders may effect these transactions by selling shares directly to purchasers or to or through broker-dealers, which may act as agents or principals. These broker-dealers may receive compensation
in the form of discounts, concessions or commissions from the selling security holders and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principals, or both (which compensation as to a particular
broker-dealer might be in excess of customary commissions). The selling security holders have advised us that they have not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the sale of
their securities. 
 The selling security holders may enter into hedging transactions with broker-dealers or other financial institutions. In
connection with those transactions, the broker-dealers or other financial institutions may engage in short sales of the shares or of securities convertible 

  

 25 

 
into or exchangeable for the shares in the course of hedging positions they assume with the selling security holders. The selling security holders may also
enter into options or other transactions with broker-dealers or other financial institutions which require the delivery of shares offered by this prospectus to those broker-dealers or other financial institutions. The broker-dealer or other
financial institution may then resell the shares pursuant to this prospectus (as amended or supplemented, if required by applicable law, to reflect those transactions). 
 The selling security holders and any broker-dealers that act in connection with the sale of shares may be deemed to be “underwriters” within the meaning of Section 2(11) of the Securities Act of 1933,
and any commissions received by broker-dealers or any profit on the resale of the shares sold by them while acting as principals may be deemed to be underwriting discounts or commissions under the Securities Act. The selling security holders may
agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the shares against liabilities, including liabilities arising under the Securities Act. We have agreed to indemnify each of the selling
security holders and each selling security holder has agreed, severally and not jointly, to indemnify us against some liabilities in connection with the offering of the shares, including liabilities arising under the Securities Act. 
 The selling security holders will be subject to the prospectus delivery requirements of the Securities Act. We have informed the selling security holders
that the anti-manipulative provisions of Regulation M promulgated under the Securities Exchange Act of 1934 may apply to their sales in the market. 
 Selling security holders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided they meet the criteria and conform to the requirements of Rule 144. 

Upon being notified by a selling security holder that a material arrangement has been entered into with a broker-dealer for the sale of shares through
a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, we will file a supplement to this prospectus, if required pursuant to Rule 424(b) under the Securities Act, disclosing: 

 

	•	 	 the name of each such selling security holder and of the participating broker-dealer(s); 

  

	•	 	 the number of shares involved; 

  

	•	 	 the initial price at which the shares were sold; 

  

	•	 	 the commissions paid or discounts or concessions allowed to the broker-dealer(s), where applicable; 

  

	•	 	 that such broker-dealer(s) did not conduct any investigation to verify the information set out or incorporated by reference in this prospectus; and

  

 26 

	•	 	 other facts material to the transactions. 

 In addition, if required under applicable law or the rules or regulations of the Commission, we will file a supplement to this prospectus when a selling security holder notifies us that a donee or pledgee intends to sell more than 500
shares of common stock. 
 We are paying all expenses and fees customarily paid by the issuer in connection with the registration of the
shares. The selling security holders will bear all brokerage or underwriting discounts or commissions paid to broker-dealers in connection with the sale of the shares. 
  

 27 

 EXHIBIT B 
 FORM OF NOTICE OF EFFECTIVENESS OF REGISTRATION STATEMENT 
 [Name and Address of Transfer Agent] 
 Re: GlobalOptions Group, Inc. 
 Dear
[                    ]: 
 We are
counsel to GlobalOptions Group, Inc., a Delaware corporation (the “Company”), and have represented the Company in connection with that certain Restructuring Agreement (the “Restructuring Agreement”) dated as of June
    , 2007 by and among the Company and the holders named therein (collectively, the “Holders”) pursuant to which the Company issued to the Holders, in accordance with the terms and conditions thereof, shares of
its Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), and shares of its Series D Convertible Preferred Stock, par value $0.001 per share (the “Series D Preferred Stock”), each
convertible into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and shares of Common Stock. Pursuant to the Restructuring Agreement, the Company has also entered into a Restructuring
Registration Rights Agreement with the Holders (the “Restructuring Registration Rights Agreement”) pursuant to which the Company agreed, among other things, to register the shares of Common Stock issuable upon conversion of the Series C
Preferred Stock and Series D Preferred Stock and the shares of Common Stock issued pursuant to the terms of the Restructuring Agreement under the Securities Act of 1933, as amended (the “1933 Act”). In connection with the Company’s
obligations under the Restructuring Registration Rights Agreement, on                     , 2007, the Company filed a Registration Statement
on Form S-     (File No. 333-                    ) (the “Registration Statement”) with the
Securities and Exchange Commission (the “SEC”) relating to the Registrable Securities which names each of the Holders as a selling securityholder thereunder. 
 In connection with the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has entered an order declaring the Registration Statement effective under the 1933 Act at
[ENTER TIME OF EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS] and we have no knowledge, after telephonic inquiry of a member of the SEC’s staff, that any stop order suspending its effectiveness has been issued or that any proceedings for that
purpose are pending before, or threatened by, the SEC. Attached is a copy of the Registration Statement as declared effective by the SEC. Set forth on page [    ] thereof is a list of the Registrable Securities
covered thereby. 
  

			
	 Very truly yours,

		
	 By:
	 	  

	 cc:
	 	 [LIST NAMES OF HOLDERS]

  

 28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]